-
Something wrong with this record ?
Treating great and small saphenous vein insufficiency with histoacryl in patients with symptomatic varicose veins and increased risk of surgery
K. Novotný, M. Roček, R. Pádr, R. Pavlík, M. Polovinčák, T. Adla, P. Zimolová, J. Choi-Širůčková, M. Weis, S. Jirát, V. Rohn,
Language English Country Switzerland
Document type Journal Article
- MeSH
- Time Factors MeSH
- Chronic Disease MeSH
- Adult MeSH
- Enbucrilate administration & dosage adverse effects MeSH
- Endovascular Procedures * adverse effects MeSH
- Kaplan-Meier Estimate MeSH
- Middle Aged MeSH
- Humans MeSH
- Prospective Studies MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Severity of Illness Index MeSH
- Embolization, Therapeutic * adverse effects MeSH
- Varicose Veins diagnostic imaging surgery therapy MeSH
- Saphenous Vein * diagnostic imaging surgery MeSH
- Treatment Outcome MeSH
- Venous Insufficiency diagnostic imaging surgery therapy MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: Treating great and small saphenous vein trunk insufficiency with cyanoacrylate glue is the least taxing treatment method of all available techniques. Due to long-term unavailability of commercial kits with n-butyl-2-cyanoacrylate (histoacryl) in the Czech Republic, we used a modified technique. PATIENTS AND METHODS: Fifty-six limbs in 49 patients suffering from great saphenous vein or small saphenous vein insufficiency in combination with symptomatic chronic venous insufficiency and complicating comorbidities were treated with a modified endovascular cyanoacrylate glue application technique. RESULTS: The immediate success rate of the treatment was 98 %. In follow-up intervals of six weeks, six months, one year, and two years, the anatomical success rates of embolization (recanalization of no more than 5 cm of the junction) were 98, 96, 94, and 94 %, respectively. At identical intervals the venous insufficiency was scored according to the Aberdeen Varicose Vein Questionnaire and the American Venous Clinical Severity Score. In both cases, improvement was demonstrated over the two-year follow-up, with a 0.5 % significance level. Specific clinical signs of venous insufficiency were also evaluated, such as pain, oedema, clearance of varicose veins, and healing of venous ulceration. One severe complication - a pulmonary embolism - was reported, without consequences. CONCLUSIONS: We demonstrated that treating insufficient saphenous veins with modified histoacryl application brought a relief from symptoms of venous insufficiency and that the efficiency of this technique is comparable to commonly used methods.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000652
- 003
- CZ-PrNML
- 005
- 20190110113409.0
- 007
- ta
- 008
- 190107s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1024/0301-1526/a000716 $2 doi
- 035 __
- $a (PubMed)29890917
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Novotný, Karel $u 1 Department of Cardiology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 245 10
- $a Treating great and small saphenous vein insufficiency with histoacryl in patients with symptomatic varicose veins and increased risk of surgery / $c K. Novotný, M. Roček, R. Pádr, R. Pavlík, M. Polovinčák, T. Adla, P. Zimolová, J. Choi-Širůčková, M. Weis, S. Jirát, V. Rohn,
- 520 9_
- $a BACKGROUND: Treating great and small saphenous vein trunk insufficiency with cyanoacrylate glue is the least taxing treatment method of all available techniques. Due to long-term unavailability of commercial kits with n-butyl-2-cyanoacrylate (histoacryl) in the Czech Republic, we used a modified technique. PATIENTS AND METHODS: Fifty-six limbs in 49 patients suffering from great saphenous vein or small saphenous vein insufficiency in combination with symptomatic chronic venous insufficiency and complicating comorbidities were treated with a modified endovascular cyanoacrylate glue application technique. RESULTS: The immediate success rate of the treatment was 98 %. In follow-up intervals of six weeks, six months, one year, and two years, the anatomical success rates of embolization (recanalization of no more than 5 cm of the junction) were 98, 96, 94, and 94 %, respectively. At identical intervals the venous insufficiency was scored according to the Aberdeen Varicose Vein Questionnaire and the American Venous Clinical Severity Score. In both cases, improvement was demonstrated over the two-year follow-up, with a 0.5 % significance level. Specific clinical signs of venous insufficiency were also evaluated, such as pain, oedema, clearance of varicose veins, and healing of venous ulceration. One severe complication - a pulmonary embolism - was reported, without consequences. CONCLUSIONS: We demonstrated that treating insufficient saphenous veins with modified histoacryl application brought a relief from symptoms of venous insufficiency and that the efficiency of this technique is comparable to commonly used methods.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a Česká republika $7 D018153
- 650 12
- $a terapeutická embolizace $x škodlivé účinky $7 D004621
- 650 _2
- $a enbukrylát $x aplikace a dávkování $x škodlivé účinky $7 D004659
- 650 12
- $a endovaskulární výkony $x škodlivé účinky $7 D057510
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a vena saphena $x diagnostické zobrazování $x chirurgie $7 D012501
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a varixy $x diagnostické zobrazování $x chirurgie $x terapie $7 D014648
- 650 _2
- $a žilní insuficience $x diagnostické zobrazování $x chirurgie $x terapie $7 D014689
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Roček, Míla $u 2 Department of Radiology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Pádr, Radek $u 2 Department of Radiology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Pavlík, Radim $u 2 Department of Radiology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Polovinčák, Michal $u 2 Department of Radiology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Adla, Theodor $u 2 Department of Radiology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Zimolová, Petra $u 3 Cardiology Clinic of the 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Choi-Širůčková, Jana $u 3 Cardiology Clinic of the 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Weis, Martin $u 4 Ambulant angiography, Prague, Czech Republic.
- 700 1_
- $a Jirát, Simon $u 5 Angiology Zbraslav, Prague, Czech Republic.
- 700 1_
- $a Rohn, Vilém $u 1 Department of Cardiology, 2nd Faculty of Medicine, Charles University, Prague and Motol University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00004632 $t VASA. Zeitschrift fur Gefasskrankheiten $x 0301-1526 $g Roč. 47, č. 5 (2018), s. 416-424
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29890917 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190110113613 $b ABA008
- 999 __
- $a ok $b bmc $g 1364691 $s 1038775
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 47 $c 5 $d 416-424 $e 20180612 $i 0301-1526 $m VASA $n VASA $x MED00004632
- LZP __
- $a Pubmed-20190107